Polymer-lipid Particle-delivered CAR1920 mRNA CAR-T Therapy for Relapsed/Refractory B-cell Lymphoma/Leukemia

Clinical trial NCT07321301 · RECRUITING

Trial details

NCT number: NCT07321301
Sponsor: Daihong Liu
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

B-cell Lymphoma Refractory

Start date: 2025-09-01
Primary completion: 2027-08-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.